CINECA IRIS Institutional Research Information System

DA SETTIMO PASSETTI, FEDERICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.508
AS - Asia 13.946
EU - Europa 12.040
SA - Sud America 1.734
AF - Africa 593
OC - Oceania 76
Continente sconosciuto - Info sul continente non disponibili 4
Totale 55.901
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.623
IT - Italia 4.551
SG - Singapore 4.112
CN - Cina 3.773
HK - Hong Kong 1.982
SE - Svezia 1.939
VN - Vietnam 1.629
BR - Brasile 1.422
DE - Germania 1.282
BG - Bulgaria 845
TR - Turchia 714
CA - Canada 693
GB - Regno Unito 610
FR - Francia 559
FI - Finlandia 518
RU - Federazione Russa 450
IN - India 366
AT - Austria 349
UA - Ucraina 347
JP - Giappone 345
KR - Corea 266
CI - Costa d'Avorio 162
CH - Svizzera 136
BD - Bangladesh 118
IQ - Iraq 102
NG - Nigeria 102
MX - Messico 95
AR - Argentina 92
PK - Pakistan 84
NL - Olanda 81
ZA - Sudafrica 76
PL - Polonia 73
BE - Belgio 72
AU - Australia 71
SN - Senegal 68
ES - Italia 63
ID - Indonesia 63
SA - Arabia Saudita 61
UZ - Uzbekistan 50
CO - Colombia 45
EC - Ecuador 44
VE - Venezuela 42
EG - Egitto 37
KE - Kenya 33
JO - Giordania 32
MA - Marocco 30
MY - Malesia 30
CZ - Repubblica Ceca 25
JM - Giamaica 24
PH - Filippine 24
AZ - Azerbaigian 21
CL - Cile 21
IE - Irlanda 21
PY - Paraguay 21
DZ - Algeria 19
PE - Perù 19
AE - Emirati Arabi Uniti 18
GR - Grecia 18
LT - Lituania 18
KZ - Kazakistan 16
TW - Taiwan 16
IR - Iran 14
UY - Uruguay 14
IL - Israele 13
OM - Oman 13
TT - Trinidad e Tobago 13
CR - Costa Rica 12
ET - Etiopia 12
LB - Libano 12
GE - Georgia 11
BJ - Benin 10
BO - Bolivia 10
DK - Danimarca 10
PT - Portogallo 10
HU - Ungheria 9
PA - Panama 9
AL - Albania 8
NP - Nepal 8
TN - Tunisia 8
PS - Palestinian Territory 7
RO - Romania 7
DO - Repubblica Dominicana 6
NI - Nicaragua 6
BF - Burkina Faso 5
BH - Bahrain 5
EE - Estonia 5
LY - Libia 5
PR - Porto Rico 5
TH - Thailandia 5
BB - Barbados 4
BN - Brunei Darussalam 4
BY - Bielorussia 4
HN - Honduras 4
KG - Kirghizistan 4
KH - Cambogia 4
MK - Macedonia 4
MN - Mongolia 4
NZ - Nuova Zelanda 4
QA - Qatar 4
RS - Serbia 4
Totale 55.814
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.894
Ashburn 2.562
Ann Arbor 2.321
Singapore 2.284
Houston 2.076
Hong Kong 1.931
Serra 1.616
Chandler 1.592
Fairfield 1.559
San Jose 1.488
Santa Clara 1.321
Dallas 1.136
Sofia 842
Milan 777
Beijing 767
Shanghai 740
Seattle 631
Wilmington 624
New York 595
Ottawa 542
Izmir 499
Cambridge 476
Los Angeles 435
Ho Chi Minh City 430
Jacksonville 420
Boardman 416
Princeton 384
Hefei 349
Council Bluffs 343
Lawrence 334
Hanoi 321
Lauterbourg 312
Nanjing 296
Vienna 289
Medford 276
Tokyo 266
Seoul 253
Frankfurt am Main 227
Des Moines 217
London 210
Dong Ket 209
Rho 180
Helsinki 165
Abidjan 162
Istanbul 159
Dearborn 155
Pisa 149
Buffalo 134
Redondo Beach 131
Rome 121
São Paulo 116
Munich 104
Chicago 100
Florence 100
Lagos 99
Nanchang 96
Bern 94
Bremen 94
San Diego 92
Columbus 90
Düsseldorf 82
The Dalles 81
Redwood City 76
Da Nang 72
Brussels 71
Ogden 70
Boulder 69
Dakar 68
Jüchen 68
Orem 67
Pune 67
Shenyang 67
Kunming 65
Hebei 59
San Francisco 53
Turku 53
Warsaw 53
Falls Church 52
Changsha 49
Lucca 49
Tashkent 48
Fuzhou 47
Haiphong 46
Nürnberg 46
Guangzhou 45
Sydney 44
Belo Horizonte 43
Johannesburg 43
Toronto 43
Rio de Janeiro 40
Tianjin 39
Auburn Hills 36
Paris 36
Baghdad 35
Norwalk 35
Nuremberg 35
Washington 35
Dhaka 32
Livorno 32
Hangzhou 31
Totale 39.683
Salva come PNG Salva come JPEG
Nome #
1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions 416
A new class of tyrosine kinase inhibitors, “pyrazolo[3,4-d]pyrimidinic”compounds, has antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer 374
TSPO ligand residence time influences human glioblastoma multiforme cell death/life balance 333
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects 299
N, N-Dialkyl-2-phenylindol-3-ylglyoxylamides.A new class of potent and selective ligands at the Peripheral benzodiazepine receptor 294
Soyasaponins from Zolfino bean as aldose reductase differential inhibitors 286
Benzofuroxane Derivatives as Multi Effective Agents for the Treatment of Cardiovascular Diabetic Complications. Synthesis, Functional Evaluation, and Molecular Modeling Studies 279
Apoptosis Therapy in Cancer: The First Single-molecule Co-activating p53 and the Translocator Protein in Glioblastoma 275
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 272
TSPO PIGA ligands promote neurosteroidogenesis and human astrocyte well-being 270
Acid Derivatives of Pyrazolo[1,5-a]pyrimidine as Aldose Reductase Differential Inhibitors 256
Two mixed valence diruthenium(ii,iii) isomeric complexes show different anticancer properties 256
Bax Activation Blocks Self-Renewal and Induces Apoptosis of Human Glioblastoma Stem Cells 254
N '-phenylindol-3-ylglyoxylohydrazide derivatives: Synthesis, structure-activity relationships, molecular modeling studies, and pharmacological action on brain benzodiazepine receptors 249
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo 248
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities 246
Deepening the Topology of the Translocator Protein Binding Site by Novel N,N-Dialkyl-2-arylindol-3-ylglyoxylamides 244
[1,2,4]Triazino[4,3-a]benzimidazole Acetic Acid Derivatives: a New Class of Selective Aldose Reductase Inhibitors 236
Anti-inflammatory effect of a novel adenosine deaminase inhibitor in experimental colitis 234
Sulfonamides incorporating heteropolycyclic scaffolds show potent inhibitory action against carbonic anhydrase isoforms I, II, IX and XII 233
TSPO-ligands prevent oxidative damage and inflammatory response in C6 glioma cells by neurosteroid synthesis 232
Structure-Activity Relationships on Purine and 2,3-Dihydropurine Derivatives as Antitubercular Agents: a Data Mining Approach 231
Allosteric modulators of human A2B adenosine receptor. 231
Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer. 231
TSPO ligand residence time: a new parameter to predict compound neurosteroidogenic efficacy 231
G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitors: Current Trends and Future Perspectives. 229
CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 227
Metformin conjugates and therapeutic use thereof 226
Functional Studies in the Year of Pulses: the case of Zolfino landraces (Phaesolus vulgaris L.) 226
A complex bearing TSPO PIGA ligand coordinated to the [Au(PEt3)]+ pharmacophore is highly cytotoxic against ovarian cancer cells 223
[1,2,4]Triazino[4,3-a]benzimidazole Acetic Acid Derivatives: A New Class of Selective Aldose Reductase Inhibitors 223
The ra structure of tellurophene-2-carboxaldehyde by using the proton NMR spectrum in an oriented phase including carbon-13 and tellurium-125 satellites 220
A mixed-valence diruthenium(ii,iii) complex endowed with high stability: from experimental evidence to theoretical interpretation 218
p53 Functional Inhibitors Behaving Like Pifithrin-β Counteract the Alzheimer Peptide Non-β-amyloid Component Effects in Human SH-SY5Y Cells. 217
Challenging clinically unresponsive medullary thyroid cancer: Discovery and pharmacological activity of novel RET inhibitors 216
Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2 214
3-aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: Tricyclic heteroaromatic derivatives as a new class of benzodiazepine receptor ligands 213
Long lasting inhibition of Mdm2-p53 interaction potentiates mesenchymal stem cell differentiation into osteoblasts 213
An update into the medicinal chemistry of translocator protein (TSPO) ligands 213
Prediction Model on Optionally Substituted 5,6-Membered Fused Ring Systems Containing C and/or N Atoms as Antifungal Agents Against Candida albicans Developed by Data Mining 212
TSPO Radioligands for Neuroinflammation: An Overview 211
A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in cancer cells 210
Identification of Anxiolytic/Nonsedative Agents among Indol-3-ylglyoxylamides Acting as Functionally Selective Agonists at the γ-Aminobutyric Acid-A (GABAA) α2 Benzodiazepine Receptor 210
3-Aryl[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: A New Class of Selective A1 Adenosine Receptor Antagonists 209
CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 209
Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of non-camptothecin Topoisomerase I (Top1) inhibitors 209
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: A Novel Template for the Design of Highly Selective A(2B) Adenosine Receptor Antagonists. 207
Benzothiopyranoindole- and pyridothiopyranoindole-based antiproliferative agents targeting topoisomerases 206
1-Substituted 2-(benzylamino)benzimidazole derivatives: compounds with H1-antihistaminic activity 205
Arylthioamides as H2S Donors:l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo 205
Structure-Based Optimization of Tyrosine Kinase Inhibitor CLM3. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies. 205
Long Residence Time at the Neurosteroidogenic 18 kDa Translocator Protein Characterizes the Anxiolytic Ligand XBD173 204
Geometrically Constrained Analogues N-Benzylindolylglyoxylylamides: [1,2,4]Triazino[4,3-a]benzimidazol-4(10H)-one Derivatives as Potential New Ligands at the Benzodiazepine Receptor. 202
Discovery of Pyrido[3′,2′:5,6]thiopyrano[4,3- d]pyrimidine-Based Antiproliferative Multikinase Inhibitors 202
Medicinal chemistry of indolylglyoxylamide TSPO high affinity ligands with anxiolytic-like effects 201
New insights in the structure-activity relationships of 2-phenylamino-substituted benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors 201
Allosteric Modulators for Adenosine Receptors: An Alternative to the Orthosteric Ligands 200
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: a novel template for the design of highly selective A(2B) adenosine receptor antagonists 199
Drug-target Residence Time: a key parameter in glial responses to TSPO ligands 199
Hydrogen Sulphide: Biopharmacological Roles in the Cardiovascular System and Pharmaceutical Perspectives. 199
Studies in search for selective ligands for GABAA/BzR receptor subtypes: synthesis and biological evaluation of 4'-modified N-(benzyl)indol-3-ylglyoxylamides 198
Pyrido[1,2-a]pyrimidin-4-one derivatives as a novel class of selective aldose reductase inhibitors exhibiting antioxidant activity 198
Residence Time (RT), a new parameter to predict neurosteroidogenic efficacy of Translocator Protein (TSPO) ligands: N,N-dialkyl-2-arylindol-3-ylglyoxylamides, a case study 198
Antineoplastic activity of the multitarget tyrosine kinase inhibitors CLM3 and CLM94 in medullary thyroid cancer in vitro 197
Novel fluorescent triazinobenzimidazole derivatives as probes for labelling human A1 and A2B adenosine receptor subtypes 196
Synthesis, DNA binding and in vitro antiproliferative activity of purinoquinazoline, pyridopyrimidopurine and pyridopyrimidobenzimidazole derivatives as potential antitumor agents 194
5-Amino-2-phenyl[1,2,3]triazolo[1,2-a][1,2,4]benzotriazin-1-one: a Versatile Scaffold to Obtain Potent and Selective A3 Adenosine Receptor Antagonists 194
2-(Benzimidazol-2-yl)quinoxalines: A Novel Class of selective Antagonists at Human A1 and A3 Adenosine Receptors Designed by 3D Database Searching 194
Benzothiopyranoindole-Based Antiproliferative Agents: Synthesis, Cytotoxicity, Nucleic Acids Interaction, and Topoisomerases Inhibition Properties. 194
Translocator protein (tspo) ligand residence time: a new parameter to predict neurosteroidogenic efficacy for n,n-dialkyl-2-arylindol-3-ylglyoxylamides (PIGAs) 194
Medicinal chemistry of indolylglyoxylamide GABAA/BzR high affinity ligands: identification of novel anxiolytic/non sedative agents 194
Refinement of Structure-activity Relationships of the Triazinobenzimidazole A1AR Antagonists 193
Identification of 5-arylidene-4-thiazolidinone derivatives endowed with dual activity as aldose reductase inhibitors and antioxidant agents for the treatment of diabetic complications 193
"2-Phenyl[1,2,3]triazole[1,2-a][1,2,4]triazin-1,5(6H)-dione: a derivative of a new tricyclic heteroaromatic system with high affinity at the benzodiazepine receptor" 192
11C-ER176, a radioligand for 18-kDa translocator protein, has adequate sensitivity to robustly image all three affinity genotypes in human brain 192
Benzo[d]isothiazoles and Matrix Metalloproteinases. Searching for Novel and Selective Inhibitors of MMP9 191
Synthesis of a Novel Purine-Containing Heterocyclic Ring System: 8,10-Dimethylindolo[2',3':5,6][1,2,4]triazino[4,3-f]purine-9,11(8H,10H,13H)dione 191
Pursuing Aldose Reductase Inhibitors through in Situ Cross-Docking and Similarity-Based Virtual Screening 191
The Anxiolytic Etifoxine Binds to TSPO Ro5-4864 Binding Site with Long Residence Time Showing a High Neurosteroidogenic Activity 191
Osteoblast differentiation and survival: A role for A2B adenosine receptor allosteric modulators. 190
Novel positive allosteric modulators of A2B adenosine receptor acting as bone mineralisation promoters 190
Targeting TSPO Reduces Inflammation and Apoptosis in an In Vitro Photoreceptor-Like Model of Retinal Degeneration 189
Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) ligands 189
Inhibition studies on carbonic anhydrase isoforms I, II, IV and IX with N-arylsubstituted secondary sulfonamides featuring a bicyclic tetrahydroindazole scaffold 189
“Synthesis and antiproliferative evaluation of new substituted Benzothiopyrano[4,3-c] condensed ring systems” 188
Synthesis of novel 1-aryl[1]benzoxepino[5,4-c]pyrazole and [1]benzoxepino[5,4-d]pyrimidine derivatives 188
3-(Fur-2-yl)-10-(2-Phenylethyl)-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one, a Novel Adenosine Receptor Antagonist with (2A)-Mediated Neuroprotective EffeCTS 187
Prediction model on optionalli substituted 5,6-membered fused ring systems containing C and/or N atoms as antifungal agents against Candida albicans developed by data mining 186
An irreversible ligand of the 18 kDa Translocator Protein induces rapidly ΔΨm collapse and activates apoptosis in human glioblastoma multiforme cells. 186
Recent Advances in the Development of Dual Topoisomerase I and II Inhibitors as Anticancer Drugs 186
The human microglial surveillant phenotype is preserved by de novo neurosteroidogenesis through the control of cholesterol homeostasis: Crucial role of 18 kDa Translocator Protein 184
Novel N(2)-Substituted Pyrazolo[3,4-d]pyrimidine Adenosine A(3) Receptor Antagonists: Inhibition of A(3)-Mediated Human Glioblastoma Cell Proliferation (dagger) 184
Synthesis of Purinobenzodiazepine and Purinobenzotriazocine derivatives, two new heterocyclic ring systems. 184
Modulation of A2B adenosine receptor by 1-benzyl-3-ketoindole derivatives 184
Discovery of the First-in-Class Dual TSPO/Carbonic Anhydrase Modulators with Promising Neurotrophic Activity 184
Novel Pyrazolo[3,4-d]pyrimidine Derivatives as ATP-competitive Inhibitors of the Epidermal Growth Factor Receptor Protein Tyrosine Kinase 183
Targeting the 18-kDa translocator protein: Recent perspectives for neuroprotection 183
New antiproliferative agents derived from tricyclic 3,4-dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazine scaffold: synthesis and pharmacological effects 182
Novel, Highly Potent Aldose Reductase Inhibitors:Cyano(2-oxo-2,3-dihydroindol-3-yl)acetic Acid Derivatives 182
A New Approach to Control the Enigmatic Activity of Aldose Reductase 182
Totale 21.678
Salva come PNG Salva come JPEG
Categoria #
all - tutte 152.531
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 152.531
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.047 100 333 155 250 673 552 120 203 144 131 234 1.152
2022/20235.403 675 817 372 540 602 693 60 397 907 30 245 65
2023/20243.696 424 364 419 224 495 722 190 108 64 92 186 408
2024/202511.047 73 407 114 690 1.195 1.074 822 539 1.030 1.422 1.162 2.519
2025/202612.842 657 1.538 1.418 940 1.217 1.110 2.675 610 815 1.107 468 287
2026/202787 87 0 0 0 0 0 0 0 0 0 0 0
Totale 56.677